Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

Attenuating risks through regulation: issues for nanotechnology in India.

Indrani Barpujari¹

¹Science and Technology Area, The Energy and Resources Institute, Lodhi Road, New Delhi 110003, India.

Journal of Biomedical Nanotechnology

|April 14, 2011

Summary

This summary is machine-generated.

Related Concept Videos

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Control Governance: Regulatory Bodies and Their Impact

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...

Microbial Corrosion

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Effect of Porous Zirconia Coating on Human Gingival Fibroblasts and Its Mechanism.

Journal of biomedical nanotechnology·2022

Same journal

Research on Mechanism of Nanometric Bone Pulp Activated with Double Gene as Bone Morphogenetic Protein 1 and Vascular Endothelial Growth Factor for Improving the Strength of Centrum in Osteoporosis.

Journal of biomedical nanotechnology·2022

Same journal

Carrier-Free Nanomedicine for Cancer Immunotherapy.

Journal of biomedical nanotechnology·2022

Same journal

Cyclovirobuxine D Brain-Targeted Liposomes Improve Cerebral Ischemia-Reperfusion Injury via Anti-Oxidant Stress and Activating Autophagy.

Journal of biomedical nanotechnology·2022

Same journal

Protective Effect of Iron Oxide Nanoparticles on Periodontal Injury in Rats by Inhibiting Collagenase-1 and Alkaline Phosphatase Expression.

Journal of biomedical nanotechnology·2022

Same journal

Targeting the Conserved Sequence of the Substrate for the Proteinase of Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) Using Nano-Networks: Efficacy, Stability, and No Cytotoxicity.

Journal of biomedical nanotechnology·2022

Developing countries face challenges in risk-based regulation, especially for nanomaterials. India

Area of Science:

Environmental Science
Chemical Regulation
Nanotechnology Risk Assessment

Background:

Developing countries like India face significant hurdles in implementing risk-based regulations due to resource and expertise limitations.
Effective risk management is crucial for developing nations, which are often ill-equipped to handle the consequences of materialized risks.
The unique properties of nanomaterials present novel regulatory challenges that existing frameworks may not adequately address.

Purpose of the Study:

To examine the applicability of India's existing chemical legislation to the regulation of nanomaterials and their associated risks.
To assess the potential of the Manufacture, Storage and Import of Hazardous Chemical Rules, 1989 for nanomaterial governance.
To explore the role of information disclosure in regulating nanotechnology.

More Related Videos

Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

Published on: September 16, 2016

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Related Experiment Videos

Last Updated: Jun 2, 2026

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System

Published on: November 22, 2016

Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering

Published on: September 16, 2016

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

Main Methods:

Analysis of the existing Indian chemical regulatory framework, specifically the Manufacture, Storage and Import of Hazardous Chemical Rules, 1989.
Evaluation of the suitability of these rules for addressing the risks posed by nanomaterials.
Comparative assessment of 'information regulation' versus traditional regulatory approaches.

Main Results:

The Manufacture, Storage and Import of Hazardous Chemical Rules, 1989 can be adapted for nanomaterial regulation but requires significant amendments.
The existing legislation's detailed information reporting and disclosure requirements are highly valuable for nanomaterial governance.
The framework offers a potential intermediate step ('information regulation') between self-regulation and command-and-control approaches.

Conclusions:

India's chemical legislation provides a foundation for nanomaterial risk regulation, emphasizing the importance of robust information gathering.
Adapting current rules can help bridge the information deficit in nanotechnology regulation and build essential regulatory experience.
Implementing amended chemical rules can facilitate a more informed and controlled approach to nanotechnology development and deployment in India.